BOSTON SCIENTIFIC CORPBSX

Market cap

$143.3B

P/E ratio

	Dec 31, 2010	Dec 31, 2011	Dec 31, 2012	Dec 31, 2013	Dec 31, 2014	Dec 31, 2015	Dec 31, 2016	Dec 31, 2017	Dec 31, 2018	Dec 31, 2019	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024
Net sales	-	-	-	-	-	-	-	-	9,823	10,735	9,913	11,888	12,682	14,240	16,747
Cost of products sold	2,599	2,659	2,349	2,174	2,210	2,173	2,424	2,593	2,813	3,116	3,465	3,711	3,956	4,345	5,257
Gross profit	5,207	4,963	4,900	4,969	5,170	5,304	5,962	6,455	7,011	7,620	6,448	8,177	8,727	9,896	11,490
Selling, General and Administrative Expense	2,580	2,487	2,535	2,674	2,902	2,873	3,099	3,294	3,569	3,941	3,787	4,359	4,520	5,190	5,984
Research and development expenses	939	895	886	861	817	876	920	997	1,113	1,174	1,143	1,204	1,323	1,414	1,615
Royalty expense	185	172	153	140	111	70	79	68	70	65	45	49	47	46	33
Amortization expense	513	421	395	410	438	495	545	565	599	699	789	741	803	828	856
Intangible asset impairment charges	65	21	142	53	195	19	11	4	35	105	460	370	132	58	386
Contingent consideration net expense (benefit)	-	-	-	-	-	-	29	-80	-21	-35	-100	-136	35	58	-5
Restructuring Charges	116	220	355	456	69	26	28	37	36	38	52	40	24	69	16
Litigation Settlement, Fee Expense	-	-	-	-	1,036	1,105	804	285	103	115	278	430	173	-111	-
Loss (Gain) on Disposal of Businesses and Assets	-	-	-	-	-	-	-	-	-	-	-	78	-22	-	-
Operating expenses	5,863	4,059	8,768	4,849	5,471	5,631	5,515	5,170	5,504	6,102	6,528	6,978	7,078	7,553	8,887
Operating income (loss)	-656	904	-3,868	120	-301	-327	447	1,285	1,506	1,518	-80	1,199	1,649	2,343	2,603
Interest expense	393	281	261	324	216	284	233	229	241	473	361	341	470	265	305
Other, net	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-16
Income (loss) before income taxes	-	642	-4,107	-223	-509	-650	177	933	1,422	687	-79	1,076	1,141	1,985	2,282
Income tax expense (benefit)	2	201	-39	-102	-390	-411	-170	828	-249	-4,013	2	36	443	393	436
Net income (loss)	-1,065	441	-4,068	-121	-119	-239	347	104	1,671	4,700	-82	1,041	698	1,592	1,846
Dividends, Preferred Stock, Stock	-	-	-	-	-	-	-	-	-	-	33	55	55	23	-
Net Income (Loss) Attributable to Noncontrolling Interest	-	-	-	-	-	-	-	-	-	-	-	-	-	1	-8
Net income (loss) attributable to Boston Scientific common stockholders	-	-	-	-	-	-	-	-	-	-	-115	985	642	1,570	1,853
Earnings Per Share, Basic	-0.7	0.29	-2.89	-0.09	-0.09	-0.18	0.26	0.08	1.21	3.38	-0.08	0.69	0.45	1.08	1.26
Earnings Per Share, Diluted	-0.7	0.29	-2.89	-0.09	-0.09	-0.18	0.25	0.08	1.19	3.33	-0.08	0.69	0.45	1.07	1.25